CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes
August 05, 2020 07:00 ET
|
CB2 Insights
Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within Dharma dispensaries and its network of support centers in Virginia.Sail will be used to...
CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020
July 08, 2020 16:45 ET
|
CB2 Insights
TORONTO, July 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB: CBIIF), will be hosting its Q1 2020 earnings call on Wednesday, July 15, 2020 at 9:00 a.m....
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
August 28, 2019 16:05 ET
|
CB2 Insights
TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company focused on mainstreaming medical cannabis to the healthcare...
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
August 20, 2019 16:35 ET
|
CB2 Insights
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Adds Former Johnson & Johnson Executive as Director
July 31, 2019 08:00 ET
|
CB2 Insights
TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019 07:11 ET
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019 07:11 ET
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update
June 24, 2019 19:21 ET
|
CB2 Insights
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Announces FY2018 Financial Results After Transformative Year
April 30, 2019 16:05 ET
|
CB2 Insights
TORONTO, April 30, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBTOF) (“CB2” or the “Company”), a leading data-analytics company focused on bringing real-world evidence driven from the...